Biodesix’ VeriStrat Helps Personalize Therapy for Elderly Patients With Lung Cancer
Data published in Journal of Thoracic Oncology.
Read More
Search Results for: lung cancer
FDA Clears ALK Automated Gene Scanner for Lung Cancer Therapy-Selection from ASI
The platform offers clinicians a way to automatically perform genetic analysis on tissue samples, stained with the Abbott ALK probe kit, and identify the ALK gene rearrangement.
Read More
Breakthrough Personalized Cancer Care Technology
Foundation Medicine relies on a LIMS for integrating lab, clinical, and EMR data
Read More
QIAGEN Submits CDx to FDA to Guide Treatment Decisions for Investigational NSCLC Drug
QIAGEN continues to expand personalized health care portfolio and content menu for modules of the QIAsymphony automation platform.
Read More
Cell Signaling Technology Gets Patent for PCR Methods for Detection of Subset of Treatable NSCLC
The methods include the amplification of DNA or RNA fusion polynucleotides from patient blood, tissue, or cells and the determination of a therapeutic regimen based on the presence of the fusion in the sample.
Read More